The area under the concentration-time curve represents total systemic drug exposure over a defined time interval. It is an important pharmacokinetic measure used to compare drug exposure between formulations, routes and experimental conditions.
Area Under the Concentration–Time Curve
The area under the concentration-time curve represents total systemic drug exposure over a defined time interval. It is an important pharmacokinetic measure used to compare drug exposure between formulations, routes and experimental conditions.
\(AUC_{0}\to\infty = \int_{0}^\infty C(t) dt; \text{ for } linear pharmacokinetics after IV administration, AUC_{0}\to\infty = AUC_{0}^{t} + C_{t}/k_{e}\)
What this formula means
Scientific principle
Principle
Plasma drug concentration changes over time. Integrating concentration with respect to time calculates the total area beneath the concentration-time curve.
Derivation
Let C(t) represent plasma drug concentration as a function of time.
The area accumulated between time zero and time T is AUC₀→T = ∫₀ᵀ C(t) dt.
For complete exposure, the integration interval can extend to infinity.
Therefore, AUC₀→∞ = ∫₀^∞ C(t) dt.
For a one-compartment IV bolus model with first-order elimination, C(t) = C₀e^(−kt).
Integration gives AUC₀→∞ = C₀/k.
Since C₀ = A₀/Vd and k = CL/Vd, the relationship becomes AUC₀→∞ = A₀/CL.
For linear IV pharmacokinetics, this is commonly expressed as AUC₀→∞ = Dose/CL.
Final Result
AUC₀→∞ = ∫₀^∞ C(t) dt. For linear IV pharmacokinetics, AUC₀→∞ = Dose/CL.
Variables and their meanings
AUC
Area under the plasma concentration-time curve.
C(t)
Plasma drug concentration at time t.
T
End of the measured observation interval.
Dose
Administered drug amount in the model.
CL
Total body clearance.
K
First-order elimination rate constant.
SI units and conversions
Concentration
mg·L⁻¹.
Time
h.
AUC
mg·h·L⁻¹.
Dose
mg.
Clearance
L·h⁻¹.
Conditions of use
Concentration measurements must be reliable and appropriately timed.
The integration interval must be clearly defined.
Dose/clearance equivalence applies to linear pharmacokinetics after IV administration.
For extravascular administration, bioavailability must be considered.
The extrapolated terminal portion of AUC requires an appropriate elimination model.
Limitations and assumptions
Sparse concentration measurements can make AUC estimation uncertain.
AUC describes total exposure but does not independently describe peak concentration or time to peak.
Nonlinear pharmacokinetics may invalidate simple dose-proportional relationships.
Incomplete terminal sampling can cause inaccurate extrapolation.
Different concentration-time profiles can have similar AUC values.
Step-by-step worked examples
| Problem | Solution | Answer |
|---|---|---|
A theoretical IV pharmacokinetic model has an administered amount of 300 mg and total clearance of 15 L·h⁻¹. Calculate the total AUC under linear pharmacokinetics. |
| The theoretical total AUC is 20 mg·h·L⁻¹. |
A concentration-time curve is approximated by a constant concentration of 4 mg·L⁻¹ over a 3-hour interval. Calculate the AUC over that interval. |
| AUC over the 3-hour interval is 12 mg·h·L⁻¹. |
Real-world applications
Measuring systemic drug exposure.
Comparing generic and reference formulations.
Studying pharmacokinetic equivalence.
Investigating drug absorption and elimination.
Analyzing concentration-time data in clinical research.
Formula Meaning
The area under the concentration-time curve represents total systemic drug exposure over a defined time interval. It is an important pharmacokinetic measure used to compare drug exposure between formulations, routes and experimental conditions.
Sources and further reading
No source has been supplied for this item yet. Treat the claim as needing editorial verification.